PTC Therapeutics: Fourth Quarter Financial Highlights

PTC Therapeutics Reports Fourth Quarter Financial Results

PTC Therapeutics Inc., headquartered in Warren, New Jersey, announced on Thursday that it recorded a net loss of $135 million for the fourth quarter.

The company reported a quarterly loss of $1.67 per share.

These figures fell short of analyst expectations. According to a survey by Zacks Investment Research, seven analysts had predicted a much smaller loss of $0.21 per share.

During the same period, the biopharmaceutical firm generated $164.7 million in revenue, which also did not meet projections. Four analysts polled by Zacks had anticipated revenue of $304.7 million.

For the full year, PTC Therapeutics posted a profit of $682.6 million, or $7.78 per share, with total revenue reaching $1.73 billion.